MedTrace Logo

Aging Mastery Program® (AMP) Evaluation

NCT03342729 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2019-12-10

No results posted yet for this study

Summary

The Aging Mastery Program® (AMP) is designed to inform, encourage, and support older adults as they take steps to improve their lives and stay engaged in their communities. The program incorporates evidence-informed materials, expert speakers, group discussion, peer support, and small rewards to give participants the skills and tools they need to achieve measurable improvements in managing their health, remaining economically secure, and contributing actively to society. L.A. CAPRA in partnership with the National Council on Aging, City of Los Angeles and the Los Angeles County Department of Aging will evaluate the effectiveness of the AMP program across 5 community-based senior sites. The overall objective of the proposed study is to evaluate the effectiveness of AMP program on improving the health and well-being of older adults using a randomized wait-list controlled trial.

Conditions

  • Aging
  • Older Adults
  • Healthy

Interventions

BEHAVIORAL

Intervention

Participants receive the AMP 10-week program immediately

BEHAVIORAL

Control

Participants will not received the AMP 10-week program immediately, rather will wait 3-months

Sponsors & Collaborators

  • The National Council on Aging

    collaborator UNKNOWN

  • City of Los Angeles Department of Aging

    collaborator UNKNOWN

  • Los Angeles County Area Agency on Aging

    collaborator UNKNOWN

  • University of California, Los Angeles

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2018-03-15
Completion
2018-03-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03342729 on ClinicalTrials.gov